PharmaNetics Inc. is taking traditional diagnostics one step further by developing products that improve treatments on the fly. For example, the company believes that its new partnership with Bayer Diagnostics to develop platelet inhibitor diagnostics will improve GPIIb/IIIa inhibitor therapy and decrease the potential for bleeding episodes by providing physicians the ability to monitor such drugs at the